Blog

A hearing was held in Newark recently, regarding the new proposed rules that will, if promulgated, prohibit prescribers from accepting uncapped compensation from pharmaceutical companies. Drug companies have previously been permitted to provide prescribing physicians with lavish meals, compensation for consulting work, and speaking engagements—or at least there has been […]

Teens look forward to earning their driver’s license. With a driver’s license comes more freedom and independence. Unfortunately, parents are not always quite as enthusiastic about this milestone in their children’s lives. Teen drivers lack experience and are more prone to taking risks. Add distraction to the equation and parents […]

The aggressive marketing of a drug named Nuedexta to seniors has many questioning the ethics of big pharma and the doctors they work with. Nuedexta is approved to treat pseudobulbar affect (PBA), a condition that affects around one percent of Americans. Recent sales efforts focused on expanding the drug’s use […]

There has been much confusion surrounding the issue of what is considered a safe following distance. Without a standardized definition, many drivers are not leaving enough space between themselves and the drivers in front of them. A recent study confirms that such a standardized definition should be created to prevent […]